"synopsis" may belong to another edition of this title.
Shipping:
FREE
Within U.S.A.
Book Description Hardcover. Condition: new. Seller Inventory # 9780306448201
Book Description Condition: New. Seller Inventory # 658700-n
Book Description Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The recent developments in modern vaccinology are mainly based on: (i) cloning of microbial genes into recombinant vectors containing genetic information for expression of desired neutralizing immunogens; (ii) alternatives of attenuated vectors with deleted genes permitting the insertion of several foreign genes expressing antigens exposed to the host immune system during the abortive replication of such vectors; (iii) combined vaccines with the aim to protect against many diseases with a limited number of administrations; (iv) evidence demonstrating the ability of animals to respond serologically to DNA injections considered as a potential method of vaccination; (v) the possibility to manipulate the immune system with new and improved immunomodulators enhancing the immune response; and (vi) new microcarrier systems for particular immunogens or immunomodulators delivery, either in a single dose or sustained release, and presentation to the immune system for a relevant response. New vaccines being developed are mainly based on viral, bacterial or other vectors modified with genetic engineering technology, to possess and express desired antigens for vaccination against single or multiple infections. Existing combined vaccines like diphtheria, tetanus, pertussis (DTP) are also experimented with new additional components like recombinant hepatitis B virus surface antigen, inactivated poliovirus, and Haemophilus inJluenzae type b immunogens, in order to produce multivalent vaccines. Such types of vaccines permitting the reduction of multiple medical visits is of particular interest to pediatric immuni zation programs, and would benefit especially the developing countries assuring better vaccine compliance with immunization schedules. 412 pp. Englisch. Seller Inventory # 9780306448201
Book Description Condition: New. Seller Inventory # ABLIING23Feb2215580099174
Book Description Gebunden. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. The recent developments in modern vaccinology are mainly based on: (i) cloning of microbial genes into recombinant vectors containing genetic information for expression of desired neutralizing immunogens (ii) alternatives of attenuated vectors with deleted. Seller Inventory # 5902260
Book Description Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9780306448201_lsuk
Book Description Condition: New. Seller Inventory # 658700-n
Book Description Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The recent developments in modern vaccinology are mainly based on: (i) cloning of microbial genes into recombinant vectors containing genetic information for expression of desired neutralizing immunogens; (ii) alternatives of attenuated vectors with deleted genes permitting the insertion of several foreign genes expressing antigens exposed to the host immune system during the abortive replication of such vectors; (iii) combined vaccines with the aim to protect against many diseases with a limited number of administrations; (iv) evidence demonstrating the ability of animals to respond serologically to DNA injections considered as a potential method of vaccination; (v) the possibility to manipulate the immune system with new and improved immunomodulators enhancing the immune response; and (vi) new microcarrier systems for particular immunogens or immunomodulators delivery, either in a single dose or sustained release, and presentation to the immune system for a relevant response. New vaccines being developed are mainly based on viral, bacterial or other vectors modified with genetic engineering technology, to possess and express desired antigens for vaccination against single or multiple infections. Existing combined vaccines like diphtheria, tetanus, pertussis (DTP) are also experimented with new additional components like recombinant hepatitis B virus surface antigen, inactivated poliovirus, and Haemophilus inJluenzae type b immunogens, in order to produce multivalent vaccines. Such types of vaccines permitting the reduction of multiple medical visits is of particular interest to pediatric immuni zation programs, and would benefit especially the developing countries assuring better vaccine compliance with immunization schedules. Seller Inventory # 9780306448201
Book Description Condition: New. Reviews the findings on vaccines research, development, and potency trials. This book includes discussions of attenuated vectors, polynucleotides, AIDS, and many other subjects. It intends to provide public health professionals with a tool to help in the global control of infectious diseases. Editor(s): Kurstak, Edouard. Num Pages: 398 pages, biography. BIC Classification: MJCM; MMG. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 254 x 178 x 24. Weight in Grams: 1660. . 1994. Hardback. . . . . Seller Inventory # V9780306448201
Book Description Condition: New. Reviews the findings on vaccines research, development, and potency trials. This book includes discussions of attenuated vectors, polynucleotides, AIDS, and many other subjects. It intends to provide public health professionals with a tool to help in the global control of infectious diseases. Editor(s): Kurstak, Edouard. Num Pages: 398 pages, biography. BIC Classification: MJCM; MMG. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 254 x 178 x 24. Weight in Grams: 1660. . 1994. Hardback. . . . . Books ship from the US and Ireland. Seller Inventory # V9780306448201